Gordona aurantiaca (Rhodococcus aurantiacus) was described by Tsukamura and Mizuno (9) in 1971 as a new species of the genus Gordona, which was proposed as an intermediate between the genera Mycobacterium and Nocardia (3) . In 1974, Tsukamura (4) proposed to revive the generic name Rhodococcus for organisms of the genus Gordona and for so-called rhodochrous organisms. At that time, he included G. aurantiaca in the genus Rhodococcus and named it R. aurantiacus. However, G. aurantiaca (R. aurantiacus) was different from other rhodococci in several characters (3-5, 8, 10) . Goodfellow et al. (1) considered this organism as belonging to a new genus. In addition, in a numerical classification carried out by Tsukamura et al. (10) the organism appeared to be outside the genus Rhodococcus. The taxonomic position of this organism is still uncertain, but it seems to be closely related to species of Mycobacterium, Rhodococcus, and Nocardia.
Until now, 14 strains of this organism have been isolated in our laboratory, and all were obtained from the sputa of patients with tuberculous or tuberculosis-like lung diseases. However, there is no report that this organism has caused disease in humans. We report here one case in which this organism caused lung disease in a human.
MATERIALS AND METHODS
To isolate organisms, we combined a sputum specimen with an equal volume of a 4% NaOH solution, homogenized the mixture by shaking it mechanically at room temperature for 15 to 20 min, and inoculated it onto Ogawa egg medium slants with a pipette which delivered 0.1-ml samples. The inoculated tubes were incubated at 37°C for 8 weeks, and growing colonies were examined for susceptibility to p-nitrobenzoic acid (0.5 mg/ml), on which Mycobacterium tuberculosis and M. bovis cannot grow but other mycobacteria, rhodococci, and nocardiae can grow (11) . Isolates other than M. tuberculosis were identified by methods described previously (6, 7) .
RESULTS AND DISCUSSION
Case report. A 50-year-old male farmer who was a resident of Fukuoka Prefecture was examined by X ray every year, and no pathological finding was made until 1980. Beginning on 27 August 1981, the patient had a fever (38.5°C) and a pain in his left thorax, and he was hospitalized in the Fukuoka Higashi Hospital on 4 September. At the hospital, he suffered from coughing and sputum production, and X rays showed a small fibrocaseous lesion in the form of a cavity in his left upper lobe and a pleural effusion in the same side. He was treated daily with a combination of streptomycin (0.5 g, intramuscularly), isoniazid (0.4 g), and rifampin (0.45 g) for 2 months. He was 157 cm tall and weighed 48 kg. Thereafter, the administration of streptomycin was reduced to twice weekly, and the treatment was continued. Owing to this chemotherapy, the fever and pleural effusion disappeared after 1 month, and the lesion in the left upper lobe was also reduced slightly but remained visible in an X ray as late as February 1982. Slightly acid-fast organisms were isolated seven times from the sputa: 5 7 December, and 21 December, respectively) were studied taxonomically in the Chubu Hospital, and all were identified as G. aurantiaca.
The four isolates showed resistance to streptomycin (20 ,ug/ml), p-aminosalicylate (1 ,ug/ml), closerine (40 ,ug/ml), ethionamide (25 ,ug/ml), rifampin (25 pLg/ml), and ethambutol (5 ,ug/ml) and showed partial resistance to enviomycin (100 Vig/ml) and capreomycin (100 p.g/ml) in Ogawa egg medium. G. aurantiaca was described by Tsukamura and Mizuno (9) in 1971 in a Japanese journal with an English summary and tables. We describe below the characters of the type strain ATCC 25938. The methods of testing the characters are described in previous papers (6, 7) .
G. aurantiaca cells are weakly acid-fast rods (length, 2 to 5 pm) but may be strongly acid-fast rods. A mycelium is not formed. The cells form rough, dry, brownish, scotochromogenic colonies on egg media as well as on a modified Sauton agar (glutamate was substituted for asparagine). They grow at 28 and 37°C after 3 days but not at 42°C or above.
G. aurantiaca is resistant to p-aminosalicylate (2 mg/ml), salicylate (1 mg/ml), p-nitrobenzoic acid (0.5 mg/ml), hydroxylamine hydrochloride (0.5 mg/ml), ethambutol (5 p.g/ml), rifampin (25 ,ug/ml), isoniazid (10 ,ug/ml), and 5% NaCl in Ogawa egg medium (or Lowenstein-Jensen medium). It is resistant to picric acid (0.2%), salicylate (0.1%), and nitrite (0.2%) in a modified Sauton agar.
Niacin is not produced; p-aminosalicylate and salicylate are not degraded to catechol; it is arylsulphatase negative (14 days), catalase positive (semiquantitative method), a-esterase negative, 3-esterase positive, ,B-galactosidase positive, and acid phosphatase negative (3 h). Nitrate is not reduced to nitrite after 24 h. Tween 80 is not hydrolyzed after 14 days. It is acetamidase, urease, nicotinamidase, pyrazinamidase, and allantoinase positive but benzamidase, isonicotinamidase, salicylamidase, and succinamidase negative.
Glutamate, serine, glucosamine hydrochloride, acetamide, and monoethanolamine are utilized as simultaneous nitrogen and carbon sources, but benzamide and trimethylene diamine are not. Acetate, citrate, succinate, malate, pyruvate, and fumarate are utilized as sole carbon sources in the presence of ammoniacal nitrogen, but benzoate and malonate are not. Glucose, fructose, sucrose, mannose, galactose, trehalose, inositol, mannitol, and sorbitol are utilized as sole carbon sources in the presence of ammoniacal nitrogen, but arabinose, xylose, and rhamnose are not. Ethanol, n-propanol, n-butanol, isobutanol, propylene glycol, and 2,3-butylene glycol are utilized as sole carbon sources in the presence of ammoniacal nitrogen, but 1,3-and 1,4-butylene glycols are not. Serine, methionine, acetamide, urea, pyrazinamide, nicotinamide, isonicotinamide, succinamide, nitrate, and nitrite are utilized as sole nitrogen sources in the presence of glycerol carbon, but benzamide is not.
The four isolates were studied in terms of all the above characters and were identified as G. aurantiaca. A few differences between our isolates and the type strain were observed: two of our isolates were not resistant to hydroxylamine (0.5 mg/ml); all four isolates hydrolyzed Tween 80 after 14 days; two were 1-esterase negative;
and none of the four utilized monoethanolamine as simultaneous nitrogen and carbon sources.
Differentiation of this organism from mycobacteria is important since the organism may occur occasionally as acid-fast rods. The differentiation is done by tests for the absence of arylsulphatase activity (after 14 days) of this organism. Resistance to mitomycin C (5 p,g/ml)
in Ogawa egg medium is also useful since all rapidly growing mycobacteria, except for M. fortuitum and M. chelonei, are susceptible to it (8) . Differentiation from M. fortuitum and M. chelonei is easily made since these mycobacteria show arylsulphatase activity even after 3 days and usually can degrade p-aminosalicylate and produce a black formazan (2) ( Table 1) .
Differentiation from rhodococci is made by tests for 3-galactosidase activity (5), resistance to mitomycin C (5 p.g/ml) (8) , absence of nitrate reduction activity, and utilization of galactose as the sole carbon source in the presence of ammoniacal nitrogen (Table 1) . Differentiation from nocardiae is made by tests for the absence of a temporary mycelium and the utilization of sucrose, sorbitol, or both as sole carbon sources in the presence of ammoniacal nitrogen (Table 1 ).
